DPAGT1, an acronym for Dolichyl-Phosphate N-Acetylglucosaminephosphotransferase 1, is an enzyme that plays a pivotal role in the N-linked glycosylation pathway, a process essential for the proper folding and function of many proteins. This enzyme catalyzes the first committed step in the synthesis of the dolichol-linked oligosaccharide precursor, which is then transferred to nascent proteins in the endoplasmic reticulum (ER). The activity of DPAGT1 is not only crucial for protein quality control but also for maintaining cellular homeostasis. Given its central role in protein maturation, cells have evolved mechanisms to upregulate DPAGT1 expression in response to various forms of cellular stress, particularly those that disrupt protein folding within the ER, a condition known as ER stress. The regulation of DPAGT1 is thus tightly linked to the unfolded protein response (UPR), a cellular stress response related to the ER.
Several chemical compounds have been identified that can induce the expression of DPAGT1. These activators often function by eliciting a stress response within the cell or by directly interfering with the glycosylation pathway, thereby triggering compensatory mechanisms to restore balance. For instance, molecules like tunicamycin, which directly inhibits the function of DPAGT1, can lead to an increase in the enzyme's expression as the cell attempts to bypass the blockage. Similarly, thapsigargin, which induces ER stress by disrupting calcium homeostasis, can result in the upregulation of DPAGT1 as part of the UPR. Other compounds, such as dexamethasone and 4-phenylbutyrate, may stimulate DPAGT1 expression through their roles in modulating cellular stress and protein folding pathways. These activators, while diverse in structure and primary function, share the common outcome of upregulating DPAGT1, highlighting the enzyme's importance in cellular adaptation to both internal and external perturbations.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin是一种有效的ER应激诱导剂,通过阻断ER中的钙泵,依次激活未折叠蛋白反应,通常导致DPAGT1上调以缓解应激。 | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
作为糖皮质激素,地塞米松可通过受体介导的机制刺激DPAGT1的表达,从而增强细胞应对蛋白质折叠和ER相关降解需求增加的能力。 | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $75.00 $163.00 $622.00 $4906.00 $32140.00 | 43 | |
苯丁酸钠作为一种化学伴侣,可以减少蛋白质的错误折叠和内质网应激,从而增加DPAGT1的表达,以支持增强的蛋白质折叠能力。 | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132通过抑制泛素-蛋白酶体途径,导致蛋白质积累和ER应激,从而触发DPAGT1表达的增加,作为细胞恢复稳态反应的一部分。 | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
氯化锂能刺激 Wnt 信号通路,而已知的 Wnt 信号通路能上调参与糖基化过程的基因,包括 DPAGT1,以支持细胞的生长和维持。 | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
维甲酸通过与维甲酸受体的相互作用,可以刺激细胞分化与蛋白质加工相关基因的转录,包括DPAGT1的上调。 | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-雌二醇可刺激雌激素受体信号通路,从而导致 DPAGT1 表达上调,促进蛋白质的有效加工和成熟。 | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
丁酸钠是一种组蛋白去乙酰化酶抑制剂,可导致组蛋白过度乙酰化,从而增加各种基因的转录,可能刺激DPAGT1的上调。 | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Sp1 抑制因子 Mithramycin A 可以破坏正常的转录物模式,这可能会引发 DPAGT1 表达的代偿性上调,以维持糖基化过程。 | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $33.00 $102.00 | 87 | |
Salubrinal 以 eIF2α 磷酸酶为靶标,导致激活 ER 应激反应,其中通常包括 DPAGT1 的上调,以应对蛋白质合成需求的增加。 |